Chronic Laryngitis (Investigational Cervical Adjunct)

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?

Not FDA-cleared for chronic laryngitis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.

Welche Evidenz existiert?

Tier C (investigational). No controlled trials. Evidence-based first-line management is identifying and treating the underlying cause: voice rest and speech therapy for voice misuse, proton pump inhibitor therapy and lifestyle changes for reflux laryngitis, smoking cessation, treatment of allergies, and ENT evaluation including stroboscopic laryngoscopy to rule out vocal cord lesions or malignancy.

Hauptrisiken

• Bleeding from each bite site for 6 to 10 hours after the leech detaches
• Iron-deficiency anemia from cumulative blood loss across multiple sessions
• Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
• Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
• Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
• Local pain, bruising, swelling, or itching for 1 to 3 days after each session
• Cervical placement risks (proximity to airway, vessels, recurrent laryngeal nerve)
• Delaying laryngoscopic workup that might detect early laryngeal cancer in a high-risk patient

Wer dies nicht in Betracht ziehen sollte

• Patients who have not had laryngoscopy with a chronic voice change lasting more than 3-4 weeks
• Smokers or heavy drinkers — laryngeal cancer screening is paramount
• Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
• People with hemophilia or any other inherited bleeding disorder
• Patients with severe anemia (hemoglobin under 10 g/dL)
• People with an active infection at the planned application site
• Patients who are pregnant or breastfeeding (relative contraindication; insufficient safety data)

Was Sie Ihren Kliniker fragen sollten

• Have I had direct laryngoscopy to rule out vocal cord lesions or cancer?
• Have reflux, voice misuse, smoking, and allergy each been addressed?
• What is the published evidence base for leeches in chronic laryngitis?
• How will leech therapy be performed safely in the cervical area?
• How will worsening of an underlying laryngeal lesion be detected during the course?
• What is the success metric — voice quality, endoscopic appearance, both?

Wann dringende medizinische Versorgung suchen

• Bleeding from a bite site that soaks through more than one dressing per hour
• Bleeding that continues more than 24 hours after the leech detached
• Spreading redness, warmth, swelling, pus, or red streaks around any bite site
• Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
• Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
• Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
• Persistent hoarseness lasting more than 2 weeks (requires urgent ENT laryngoscopy in smokers)
• Coughing up blood, difficulty swallowing solid food, unexplained weight loss, or neck mass
• Stridor or difficulty breathing